Brexpiprazole for schizophrenia and as adjunct for major depressive disorder
Descrição
PDF) Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study
Brexpiprazole Short-Term Clinical Study Designs for the Adjunctive
PDF) Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
PDF] Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
Brexpiprazole in the Treatment of Major Depressive Disorder - Document - Gale OneFile: Health and Medicine
Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression. - Abstract - Europe PMC
Brexpiprazole Semantic Scholar
Brexpiprazole: Package Insert
Efficacy and safety of brexpiprazole in acute management of psychiatric disorders: a meta-analysis of randomized controlled trials
Brexpiprazole Updated - Gateway Psychiatric
Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
